Nuveen’s ACELYRIN SLRN Stock Holding History

Nuveen’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-202,239	Closed	-$500K	–	3395
2025 Q1	$500K	Hold	202,239	–	–	﹤0.01%	2906
2024 Q4	$635K	Hold	202,239	–	–	﹤0.01%	2900
2024 Q3	$997K	Buy	202,239 +10,782	+6%	+$55.7K	﹤0.01%	2766
2024 Q2	$844K	Hold	191,457	–	–	﹤0.01%	2802
2024 Q1	$1.29M	Buy	191,457 +123,686	+183%	+$940K	﹤0.01%	2588
2023 Q4	$506K	Buy	67,771 +22,835	+51%	+$195K	﹤0.01%	2997
2023 Q3	$457K	Buy	+44,936	New	+$954K	﹤0.01%	2869

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nuveen's SLRN Position: Q2 2025 in Review

Nuveen sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 202,239 shares — an estimated $500K sold.

Nuveen first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $1.29M in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Nuveen reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Nuveen sold 202,239 ACELYRIN shares in Q2 2025, an estimated $500K.
Nuveen first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
Nuveen's ACELYRIN position peaked at $1.29M in Q1 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.